|
RPIA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.997250E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.620600E-04 |
| Normal-vs-Stage2 |
6.530100E-02 |
| Normal-vs-Stage3 |
1.581980E-02 |
| Normal-vs-Stage4 |
2.657200E-03 |
| Stage1-vs-Stage2 |
6.918800E-01 |
| Stage1-vs-Stage3 |
6.662400E-01 |
| Stage1-vs-Stage4 |
4.631000E-01 |
| Stage2-vs-Stage3 |
9.711800E-01 |
| Stage2-vs-Stage4 |
4.170800E-01 |
| Stage3-vs-Stage4 |
3.406200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.835200E-04 |
| Normal-vs-AfricanAmerican |
2.764900E-03 |
| Normal-vs-Asian |
1.028250E-02 |
| Caucasian-vs-AfricanAmerican |
2.561400E-01 |
| Caucasian-vs-Asian |
3.392400E-01 |
| AfricanAmerican-vs-Asian |
6.442800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.784100E-03 |
| Normal-vs-Female |
1.56913999999064E-05 |
| Male-vs-Female |
3.584200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.259700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.174800E-04 |
| Normal-vs-Age(61-80Yrs) |
5.386100E-04 |
| Normal-vs-Age(81-100Yrs) |
7.022200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.435800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.233800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.678400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.580800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.953200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.588810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.234420E-04 |
| Normal-vs-Grade 2 |
7.96130000000339E-05 |
| Normal-vs-Grade 3 |
1.445630E-02 |
| Normal-vs-Grade 4 |
6.045000E-03 |
| Grade 1-vs-Grade 2 |
6.051600E-02 |
| Grade 1-vs-Grade 3 |
3.113600E-02 |
| Grade 1-vs-Grade 4 |
2.011600E-01 |
| Grade 2-vs-Grade 3 |
1.203780E-01 |
| Grade 2-vs-Grade 4 |
8.298200E-01 |
| Grade 3-vs-Grade 4 |
2.210000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.65979999999988E-05 |
| Normal-vs-ccB subtype |
6.722000E-02 |
| ccA subtype-vs-ccB subtype |
6.318400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.838430E-03 |
| Normal-vs-N1 |
8.741800E-02 |
| N0-vs-N1 |
4.950400E-01 |
|
|
